Taking CAR-T Cells Beyond Cancer: A New Therapy for Autoimmune Disease
CAR-T cells are all the rage as the latest treatment for cancer. But what if…
CAR-T cells are all the rage as the latest treatment for cancer. But what if…
TxCell has received a €1.2 loan from Bpifrance to complete preclinical trials with its CAR-Treg…
Juno’s JCAR015 study came to a halt for the second time this year after two…
TxCell is restarting its trial for Ovasave, an autologous T-cell therapy, with a new manufacturing…
TxCell and Ospedale San Raffaele have partnered up to research a new treatment for Lupus,…
Today is Rare Disease Day 2016. Because it is an important field for Biotech, we…
Which part of our body do European biotechs prefer to target? And how diversified are…
We all know the success stories linked to Rare Disease such as Genzyme. But I…
Now, as we've recently discussed here at Labiotech, there doesn't appear to be many Welsh…
TxCell, from Nice (Fr), has been granted EU and US Orphan Drug Designation for its…